Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Agric Food Chem ; 72(8): 3984-3997, 2024 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-38357888

RESUMEN

Plant secondary metabolites are critical quality-conferring compositions of plant-derived beverages, medicines, and industrial materials. The accumulations of secondary metabolites are highly variable among seasons; however, the underlying regulatory mechanism remains unclear, especially in epigenetic regulation. Here, we used tea plants to explore an important epigenetic mark DNA methylation (5mC)-mediated regulation of plant secondary metabolism in different seasons. Multiple omics analyses were performed on spring and summer new shoots. The results showed that flavonoids and theanine metabolism dominated in the metabolic response to seasons in the new shoots. In summer new shoots, the genes encoding DNA methyltransferases and demethylases were up-regulated, and the global CG and CHG methylation reduced and CHH methylation increased. 5mC methylation in promoter and gene body regions influenced the seasonal response of gene expression; the amplitude of 5mC methylation was highly correlated with that of gene transcriptions. These differentially methylated genes included those encoding enzymes and transcription factors which play important roles in flavonoid and theanine metabolic pathways. The regulatory role of 5mC methylation was further verified by applying a DNA methylation inhibitor. These findings highlight that dynamic DNA methylation plays an important role in seasonal-dependent secondary metabolism and provide new insights for improving tea quality.


Asunto(s)
Camellia sinensis , Metilación de ADN , Metabolismo Secundario , Estaciones del Año , Epigénesis Genética , Hojas de la Planta/genética , Hojas de la Planta/metabolismo , Camellia sinensis/genética , Camellia sinensis/metabolismo , Flavonoides/metabolismo , Té/metabolismo , Regulación de la Expresión Génica de las Plantas , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo
2.
Mar Drugs ; 16(5)2018 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-29772753

RESUMEN

Recently, accumulating evidence has suggested that Enteromorpha clathrata polysaccharide (ECP) could contribute to the treatment of diseases. However, as a promising candidate for marine drug development, although ECP has been extensively studied, less consideration has been given to exploring its effect on gut microbiota. In this light, given the critical role of gut microbiota in health and disease, we investigated here the effect of ECP on gut microbiota using 16S rRNA high-throughput sequencing. As revealed by bioinformatic analyses, ECP considerably changed the structure of the gut microbiota and significantly promoted the growth of probiotic bacteria in C57BL/6J mice. However, interestingly, ECP exerted different effects on male and female microbiota. In females, ECP increased the abundances of Bifidobacterium spp. and Akkermansia muciniphila, a next-generation probiotic bacterium, whereas in males, ECP increased the population of Lactobacillus spp. Moreover, by shaping a more balanced structure of the microbiota, ECP remarkably reduced the antigen load from the gut in females. Altogether, our study demonstrates for the first time a prebiotic effect of ECP on gut microbiota and forms the basis for the development of ECP as a novel gut microbiota modulator for health promotion and disease management.


Asunto(s)
Organismos Acuáticos/metabolismo , Disbiosis/tratamiento farmacológico , Microbioma Gastrointestinal/efectos de los fármacos , Polisacáridos/farmacología , Ulva/metabolismo , Proteínas de Fase Aguda/inmunología , Administración Oral , Animales , Bifidobacterium/efectos de los fármacos , Bifidobacterium/aislamiento & purificación , Proteínas Portadoras/sangre , Proteínas Portadoras/inmunología , Biología Computacional , Suplementos Dietéticos , Modelos Animales de Enfermedad , Disbiosis/sangre , Disbiosis/inmunología , Femenino , Humanos , Lactobacillus/efectos de los fármacos , Lactobacillus/aislamiento & purificación , Masculino , Glicoproteínas de Membrana/sangre , Glicoproteínas de Membrana/inmunología , Ratones , Ratones Endogámicos C57BL , Polisacáridos/aislamiento & purificación , Polisacáridos/uso terapéutico , Organismos Libres de Patógenos Específicos , Verrucomicrobia/efectos de los fármacos , Verrucomicrobia/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA